ETAR Blockade’s Role in Current and Emerging Therapies for IgAN– Explore the Visual Abstract
This visual abstract was supported by an unrestricted educational grant from Chinook Therapeutics, a Novartis Company.
22Jan
Share
Back to News
Back to News
Related Posts
08Jun
ISN Journal summaries on conventional cytotoxic chemotherapy and Taiwan’s living kidney donation policy
Kidney International® Conventional cytotoxic chemotherapy–associated nephrotoxicity: consensus report of the 34th Acute... read more
08Jun
Save 50% on ISN membership for the rest of 2026
Reconnect with the resources, opportunities, and community that support your professional... read more
08Jun
Reflecting on progress and looking ahead: 10 years of the ISN-Global Kidney Health Atlas
As you continue to use ISN-Global Kidney Health Atlas (ISN-GKHA) data in your... read more
08Jun
Redesigning kidney trials for improved evidence and patient care
“If a drug improves creatinine but makes a patient too fatigued... read more
08Jun
10 years of Kidney International Reports®: transforming how kidney science is shared
“We are truly a global journal: We do not just select [from]... read more
26May
ISN Collective-member network expands to Fiji
The ISN is pleased to welcome the Nephrology Society of Fiji as its... read more
26May
KICR article in focus: rare late fungal infection after kidney transplantation
A new case report in Kidney International Case Reports™ (KICR) describes... read more
26May
From resolution to action: New Lancet paper and WHA79 events spotlight kidney health
“By connecting policy, primary care, and health financing, we can help translate... read more
26May
Turn environmentally sustainable goals into action with the new ISN Green Nephrology Toolkit
Concerned about the environmental impact of kidney care but unsure where... read more
26May
Tune in to regional perspectives from the WCN’26 Kidney Studio
What do kidney care priorities look like across ISN regions? In a... read more